260 related articles for article (PubMed ID: 22261673)
1. High-risk cutaneous squamous cell carcinoma.
Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
3. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.
Farasat S; Yu SS; Neel VA; Nehal KS; Lardaro T; Mihm MC; Byrd DR; Balch CM; Califano JA; Chuang AY; Sharfman WH; Shah JP; Nghiem P; Otley CC; Tufaro AP; Johnson TM; Sober AJ; Liégeois NJ
J Am Acad Dermatol; 2011 Jun; 64(6):1051-9. PubMed ID: 21255868
[TBL] [Abstract][Full Text] [Related]
4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
5. Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.
Dimonitsas E; Champsas G; Kakagia D; Stavrianos S; Roussos S; Doryforou O; Neamonitou F; Soura E; Kostopoulos E; Christofidou E; Papadopulos O; Thymara I; Papadopulos NA; Stratigos A; Korkolopoulou P
J BUON; 2021; 26(3):1148-1158. PubMed ID: 34268983
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
7. New Developments in the Management of Cutaneous Squamous Cell Carcinoma.
Knackstedt TJ; Knackstedt RW; Djohan M; Djohan R; Gastman BR; Crowe DR
Plast Reconstr Surg; 2021 Mar; 147(3):492-504. PubMed ID: 33620947
[TBL] [Abstract][Full Text] [Related]
8. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.
Saito Y; Fujikawa H; Takatsuka S; Abe R; Takenouchi T
Int J Clin Oncol; 2021 Mar; 26(3):606-612. PubMed ID: 33175299
[TBL] [Abstract][Full Text] [Related]
10. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients.
Oh Y; Kim J; Zheng Z; Kim SK; Chung KY; Roh MR
J Dermatol; 2020 Jan; 47(1):72-77. PubMed ID: 31674043
[TBL] [Abstract][Full Text] [Related]
14. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
[TBL] [Abstract][Full Text] [Related]
15. A matched-pair study of cutaneous squamous cell carcinomas with and without lymphovascular invasion.
Levoska MA; Murad F; Schmults CD; Ruiz ES
J Am Acad Dermatol; 2020 Apr; 82(4):1001-1003. PubMed ID: 31626882
[No Abstract] [Full Text] [Related]
16. Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis.
Tanamal PJ; Geng CX; Nijhawan RI; Wynings E; Balachandra S; Myers LL; Tillman BN; Day AT
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):335-341. PubMed ID: 33956206
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5-year outcomes.
Adams A; De'Ambrosis B; Panizza B; Belt P; Emmett J; Warren T; Whiteman DC
Australas J Dermatol; 2020 Aug; 61(3):226-230. PubMed ID: 32285436
[TBL] [Abstract][Full Text] [Related]
18. Histological classification of cutaneous squamous cell carcinomas with different severity.
Schmitz L; Kanitakis J
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():11-15. PubMed ID: 31833602
[TBL] [Abstract][Full Text] [Related]
19. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
20. Approaches to Perineural, Lymphovascular, and Single-Cell Disease.
Collins MK; Behshad R; Maloney M; Pugliano-Mauro M
Dermatol Surg; 2019 Dec; 45 Suppl 2():S118-S128. PubMed ID: 31764297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
